{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T19:43:46Z","timestamp":1783367026918,"version":"3.54.6"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-024-01540-1","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T07:02:54Z","timestamp":1728370974000},"page":"1057-1070","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Computational Drug Design Approaches for the Identification of Novel Antidiabetic Compounds from Natural Resources through Molecular Docking, ADMET, and Toxicological Studies"],"prefix":"10.1007","volume":"83","author":[{"given":"Bakul","family":"Akter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Sohorab","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Rashedul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kutub Uddin","family":"Ahamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Most. Nazmin","family":"Aktar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Kamrul","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Mohammad","family":"Salamatullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouhammed","family":"Bourhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"1540_CR1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1152\/physiol.00003.2018","volume":"33","author":"N Javeed","year":"2018","unstructured":"Javeed, N., & Matveyenko, A. V. (2018). Circadian etiology of type 2 diabetes mellitus. Physiology, 33, 138\u2013150","journal-title":"Physiology"},{"key":"1540_CR2","doi-asserted-by":"crossref","unstructured":"Frankel, D. S., Wilson, P. W. & Meigs, J. B. (2010). Diabetes mellitus and cardiovascular disease. Atlas of atherosclerosis and metabolic syndrome (pp. 227\u2013252).","DOI":"10.1007\/978-1-4419-5839-6_11"},{"key":"1540_CR3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/JCP.0b013e3181e66a62","volume":"30","author":"RL Findling","year":"2010","unstructured":"Findling, R. L., Landersdorfer, C. B., Kafantaris, V., Pavuluri, M., McNamara, N. K., & McClellan, J., et al. (2010). First-dose pharmacokinetics of lithium carbonate in children and adolescents. Journal of Clinical Psychopharmacology, 30, 404\u2013410","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"1540_CR4","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.2337\/dc09-S080","volume":"32","author":"AD Association","year":"2009","unstructured":"Association, A. D. (2009). Diabetes and employment. Diabetes Care, 32, S80","journal-title":"Diabetes Care"},{"key":"1540_CR5","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3390\/ijerph16152720","volume":"16","author":"K Makrilakis","year":"2019","unstructured":"Makrilakis, K. (2019). The role of DPP-4 inhibitors in the treatment algorithm of type 2 diabetes mellitus: When to select, what to expect. International Journal of Environmental Research and Public Health, 16, 2720","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"1540_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5001\/omj.2012.68","volume":"27","author":"AB Olokoba","year":"2012","unstructured":"Olokoba, A. B., Obateru, O. A., & Olokoba, L. B. (2012). Type 2 diabetes mellitus: A review of current trends. Oman Medical Journal, 27, 269","journal-title":"Oman Medical Journal"},{"key":"1540_CR7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology, 14, 88\u201398","journal-title":"Nature Reviews Endocrinology"},{"key":"1540_CR8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MJT.0b013e3180ed42dc","volume":"15","author":"KB Moore","year":"2008","unstructured":"Moore, K. B., & Saudek, C. D. (2008). Therapeutic potential of dipeptidyl peptidase-IV inhibitors in patients with diabetes mellitus. American Journal of Therapeutics, 15, 484\u2013491","journal-title":"American Journal of Therapeutics"},{"key":"1540_CR9","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1742-1241.2006.01178.x","volume":"60","author":"A Barnett","year":"2006","unstructured":"Barnett, A. (2006). DPP\u20104 inhibitors and their potential role in the management of type 2 diabetes. International Journal of Clinical Practice, 60, 1454\u20131470","journal-title":"International Journal of Clinical Practice"},{"key":"1540_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11892-002-0078-2","volume":"2","author":"FS Celi","year":"2002","unstructured":"Celi, F. S., & Shuldiner, A. R. (2002). The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity. Current Diabetes Reports, 2, 179\u2013185","journal-title":"Current Diabetes Reports"},{"key":"1540_CR11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1358\/mf.2002.24.8.705072","volume":"24","author":"M Vazquez","year":"2002","unstructured":"Vazquez, M., Silvestre, J., & Prous, J. (2002). Experimental approaches to study PPAR gamma agonists as antidiabetic drugs,. Methods and Finding Experimental Clinical Pharmacology, 24, 515\u2013523","journal-title":"Methods and Finding Experimental Clinical Pharmacology"},{"key":"1540_CR12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MJT.0b013e3181c08081","volume":"17","author":"V Bermudez","year":"2010","unstructured":"Bermudez, V., Finol, F., Parra, N., Parra, M., P\u00e9rez, A., & Penaranda, L., et al. (2010). PPAR-\u03b3 agonists and their role in type 2 diabetes mellitus management. American Journal of Therapeutics, 17, 274\u2013283","journal-title":"American Journal of Therapeutics"},{"key":"1540_CR13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","volume":"9","author":"C Janani","year":"2015","unstructured":"Janani, C., & Kumari, B. R. (2015). PPAR gamma gene\u2013a review,. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 9, 46\u201350","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"},{"key":"1540_CR14","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-019-1270-y","volume":"19","author":"HE Lebovitz","year":"2019","unstructured":"Lebovitz, H. E. (2019). Thiazolidinediones: The forgotten diabetes medications. Current Diabetes Reports, 19, 151","journal-title":"Current Diabetes Reports"},{"key":"1540_CR15","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.2337\/diabetes.53.2007.S60","volume":"53","author":"H-I Kim","year":"2004","unstructured":"Kim, H.-I., & Ahn, Y.-H. (2004). Role of peroxisome proliferator-activated receptor-\u03b3 in the glucose-sensing apparatus of liver and \u03b2-cells. Diabetes, 53, S60\u2013S65","journal-title":"Diabetes"},{"key":"1540_CR16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.ijo.802223","volume":"27","author":"T Larsen","year":"2003","unstructured":"Larsen, T., Toubro, S., & Astrup, A. (2003). PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? International Journal of Obesity, 27, 147\u2013161","journal-title":"International Journal of Obesity"},{"key":"1540_CR17","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2174\/0929867033456729","volume":"10","author":"J Shen","year":"2003","unstructured":"Shen, J., Xu, X., Cheng, F., Liu, H., Luo, X., & Shen, J., et al. (2003). Virtual screening on natural products for discovering active compounds and target information. Current Medicinal Chemistry, 10, 2327\u20132342","journal-title":"Current Medicinal Chemistry"},{"key":"1540_CR18","unstructured":"Nuzul Hakimi Wan SALLEH, W. M., Kassim, H. & Tawang, A. (2021). Volatile components and biological activities of Pulicaria essential oils. A review. Rivista Italiana delle Sostanze Grasse, 98, 49\u201358"},{"key":"1540_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/0973-1296.108133","volume":"9","author":"GA Fawzy","year":"2013","unstructured":"Fawzy, G. A., Al Ati, H. Y., & El Gamal, A. A. (2013). Chemical composition and biological evaluation of essential oils of Pulicaria jaubertii. Pharmacognosy Magazine, 9, 28.","journal-title":"Pharmacognosy Magazine"},{"key":"1540_CR20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11694-020-00652-5","volume":"15","author":"QA Al-Maqtari","year":"2021","unstructured":"Al-Maqtari, Q. A., Mahdi, A. A., Al\u2011Ansi, W., Mohammed, J. K., Wei, M., & Yao, W. (2021). Evaluation of bioactive compounds and antibacterial activity of Pulicaria jaubertii extract obtained by supercritical and conventional methods. Journal of Food Measurement and Characterization, 15, 449\u2013456.","journal-title":"Journal of Food Measurement and Characterization"},{"key":"1540_CR21","first-page":"224","volume":"8","author":"M Algabr","year":"2016","unstructured":"Algabr, M., Al-Hajj, N., Jaber, A., Alshotobi, A., Al-suryhi, S., & Whaban, G., et al. (2016). Antibacterial and antifungal activities of the essential oil of Pulicaria jaubertii leaves. Der Pharma Chemica, 8, 224\u20138","journal-title":"Der Pharma Chemica"},{"key":"1540_CR22","first-page":"63","volume":"4","author":"R Mentouri","year":"2010","unstructured":"Mentouri, R. (2010). Antioxydant activities from the aerial parts of Pulicaria jaubertii. Advances in Natural and Applied Sciences, 4, 63\u201370","journal-title":"Advances in Natural and Applied Sciences"},{"key":"1540_CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/molecules26010203","volume":"26","author":"HA Mohammed","year":"2021","unstructured":"Mohammed, H. A., Abdelwahab, M. F., El-Ghaly, E.-S. M., & Ragab, E. A. (2021). Phytochemical characterization, in vitro anti-inflammatory, anti-diabetic, and cytotoxic activities of the edible aromatic plant; Pulicaria jaubertii. Molecules, 26, 203","journal-title":"Molecules"},{"key":"1540_CR24","unstructured":"El-Ghaly, E.-S. M., Shaheen, U., Ragab, E., El-Hila, A. A. & Abd-Allah, M. R. (2016) Bioactive constituents of Pulicaria jaubertii: A promising antihypertensive activity, Pharmacognosy Journal, 8"},{"key":"1540_CR25","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1080\/14786419.2015.1055492","volume":"30","author":"EA Ragab","year":"2016","unstructured":"Ragab, E. A., & Raafat, M. (2016). A new monoterpene glucoside and complete assignments of dihydroflavonols of Pulicaria jaubertii: Potential cytotoxic and blood pressure lowering activity. Natural Product Research, 30, 1280\u20131288","journal-title":"Natural Product Research"},{"key":"1540_CR26","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1039\/c2cs35357a","volume":"42","author":"D-L Ma","year":"2013","unstructured":"Ma, D.-L., Chan, D. S.-H., & Leung, C.-H. (2013). Drug repositioning by structure-based virtual screening. Chemical Society Reviews, 42, 2130\u20132141","journal-title":"Chemical Society Reviews"},{"key":"1540_CR27","doi-asserted-by":"crossref","unstructured":"Prieto-Mart\u00ednez, F. D., L\u00f3pez-L\u00f3pez, E., Ju\u00e1rez-Mercado, K. E. & Medina-Franco, J. L. (2019). Computational drug design methods\u2014current and future perspectives, In silico drug design (pp. 19\u201344). Elsevier","DOI":"10.1016\/B978-0-12-816125-8.00002-X"},{"key":"1540_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/25931","volume":"395","author":"RT Nolte","year":"1998","unstructured":"Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., & Kurokawa, R., et al. (1998). Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-\u03b3. Nature, 395, 137\u2013143","journal-title":"Nature"},{"key":"1540_CR29","first-page":"203","volume":"15","author":"SM Kawsar","year":"2022","unstructured":"Kawsar, S. M., Kumer, A., Munia, N. S., Hosen, M. A., Chakma, U., & Akash, S. (2022). Chemical descriptors, PASS, molecular docking, molecular dynamics and ADMET predictions of glucopyranoside derivatives as inhibitors to bacteria and fungi growth. Organic Communications, 15, 203","journal-title":"Organic Communications"},{"key":"1540_CR30","unstructured":"Studio, D. (2008). Discovery studio. Accelrys [2.1], 420"},{"key":"1540_CR31","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/bioinformatics\/btq100","volume":"26","author":"J Konc","year":"2010","unstructured":"Konc, J., & Jane\u017ei\u010d, D. (2010). ProBiS algorithm for detection of structurally similar protein binding sites by local structural alignment,. Bioinformatics, 26, 1160\u20131168","journal-title":"Bioinformatics"},{"key":"1540_CR32","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., & Gindulyte, A., et al. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44, D1202\u2013D1213","journal-title":"Nucleic Acids Research"},{"key":"1540_CR33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/ci00023a026","volume":"35","author":"FM Klein","year":"1995","unstructured":"Klein, F. M. (1995). Computer software reviews. CS ChemDraw Pro, version 3.1 for windows. Journal of Chemical Information and Computer Sciences, 35, 166\u2013167","journal-title":"Journal of Chemical Information and Computer Sciences"},{"key":"1540_CR34","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/ci040123t","volume":"44","author":"LD Mendelsohn","year":"2004","unstructured":"Mendelsohn, L. D. (2004). ChemDraw 8 ultra, windows and macintosh versions. Journal of Chemical Information and Computer Sciences, 44, 2225\u20132226","journal-title":"Journal of Chemical Information and Computer Sciences"},{"key":"1540_CR35","first-page":"076","volume":"12","author":"ME Yulianto","year":"2022","unstructured":"Yulianto, M. E., Yuniastuti, A., Rohdiana, D., Paramita, V., Ariyanto, H. D., & Amalia, R., et al. (2022). Characterization in silico of bioactive compound in tea plant as a potentials inhibitor of SARS-CoV-2 Mpro. Journal of Applied Pharmaceutical Science, 12, 076\u2013085","journal-title":"Journal of Applied Pharmaceutical Science"},{"key":"1540_CR36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43175-x","volume":"13","author":"S Akash","year":"2023","unstructured":"Akash, S., Bay\u0131l, I., Hossain, M. S., Islam, M. R., Hosen, M. E., & Mekonnen, A. B., et al. (2023). Novel computational and drug design strategies for inhibition of human papillomavirus-associated cervical cancer and DNA polymerase theta receptor by Apigenin derivatives. Scientific Reports, 13, 16565","journal-title":"Scientific Reports"},{"key":"1540_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-1","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3, 1\u201314","journal-title":"Journal of Cheminformatics"},{"key":"1540_CR38","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717","journal-title":"Scientific Reports"},{"key":"1540_CR39","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46, W257\u2013W263","journal-title":"Nucleic Acids Research"},{"key":"1540_CR40","first-page":"791","volume":"7","author":"H Tandon","year":"2019","unstructured":"Tandon, H., Chakraborty, T., & Suhag, V. (2019). A brief review on importance of DFT in drug design. Research in Medical & Engineering Science, 7, 791\u2013795","journal-title":"Research in Medical & Engineering Science"},{"key":"1540_CR41","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2174\/157340907782799390","volume":"3","author":"SM LaPointe","year":"2007","unstructured":"LaPointe, S. M., & Weaver, D. F. (2007). A review of density functional theory quantum mechanics as applied to pharmaceutically relevant systems. Current Computer-Aided Drug Design, 3, 290\u2013296","journal-title":"Current Computer-Aided Drug Design"},{"key":"1540_CR42","doi-asserted-by":"crossref","first-page":"374","DOI":"10.33263\/BRIAC134.374","volume":"13","author":"S Akash","year":"2022","unstructured":"Akash, S., Kumer, A., Chandro, A., Chakma, U., & Matin, M. M. (2022). Quantum calculation, docking, ADMET and molecular dynamics of ketal and non-ketal forms of D-glucofuranose against bacteria, black & white fungus, and triple-negative breast cancer. Biointerface Research in Applied Chemistry, 13, 374","journal-title":"Biointerface Research in Applied Chemistry"},{"key":"1540_CR43","doi-asserted-by":"crossref","unstructured":"Shivanika, C., Kumar, D., Ragunathan, V., Tiwari, P., & Sumitha, A. (2022). Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease. Journal of Biomolecular Structure & Dynamics, 40(2), 585\u2013611","DOI":"10.1080\/07391102.2020.1815584"},{"key":"1540_CR44","first-page":"B62","volume":"4","author":"RC Nirmala","year":"2013","unstructured":"Nirmala, R. C., & Gopalakrishnan, V. (2013). Homology modeling, active site prediction and targeting the anti epileptic activity through molecular docking techniques on laforin,. International Journal of Pharma and Bio Sciences, 4, B62\u2013B72","journal-title":"International Journal of Pharma and Bio Sciences"},{"key":"1540_CR45","doi-asserted-by":"crossref","first-page":"W436","DOI":"10.1093\/nar\/gkq479","volume":"38","author":"J Konc","year":"2010","unstructured":"Konc, J., & Jane\u017ei\u010d, D. (2010). ProBiS: a web server for detection of structurally similar protein binding sites,. Nucleic Acids Research, 38, W436\u2013W440","journal-title":"Nucleic Acids Research"},{"key":"1540_CR46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1573409912666160426120709","volume":"12","author":"S Bibi","year":"2016","unstructured":"Bibi, S., & Sakata, K. (2016). Current status of computer-aided drug design for type 2 diabetes. Current Computer-Aided Drug Design, 12, 167\u2013177","journal-title":"Current Computer-Aided Drug Design"},{"key":"1540_CR47","doi-asserted-by":"crossref","first-page":"e75992","DOI":"10.1371\/journal.pone.0075992","volume":"8","author":"RG Coleman","year":"2013","unstructured":"Coleman, R. G., Carchia, M., Sterling, T., Irwin, J. J., & Shoichet, B. K. (2013). Ligand pose and orientational sampling in molecular docking. PloS ONE, 8, e75992","journal-title":"PloS ONE"},{"key":"1540_CR48","doi-asserted-by":"crossref","unstructured":"Chandrasekaran, B., Al-Joubi, H., Samarneh, S., Kassab, G., Deb, P. K., Kumar, P.,...& Bataineh, Y. A. (2020). Drug-receptor interactions. Frontiers in Pharmacology of Neurotransmitters, 31\u201368","DOI":"10.1007\/978-981-15-3556-7_2"},{"key":"1540_CR49","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.drudis.2015.01.003","volume":"20","author":"J Mortier","year":"2015","unstructured":"Mortier, J., Rakers, C., Bermudez, M., Murgueitio, M. S., Riniker, S., & Wolber, G. (2015). The impact of molecular dynamics on drug design: Applications for the characterization of ligand\u2013macromolecule complexes. Drug Discovery Today, 20, 686\u2013702","journal-title":"Drug Discovery Today"},{"key":"1540_CR50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","volume":"101","author":"LZ Benet","year":"2016","unstructured":"Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the rule of 5 and drugability. Advanced Drug Delivery Reviews, 101, 89\u201398","journal-title":"Advanced Drug Delivery Reviews"},{"key":"1540_CR51","doi-asserted-by":"crossref","unstructured":"Yan, H., Xie, H., Ying, Y., Li, J., Wang, X., Xu, X. & Zheng, X. (2018). Pioglitazone use in patients with diabetes and risk of bladder cancer: A systematic review and meta-analysis, Cancer Management and Research, 1627\u20131638","DOI":"10.2147\/CMAR.S164840"},{"key":"1540_CR52","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.drudis.2020.07.017","volume":"25","author":"W Wei","year":"2020","unstructured":"Wei, W., Cherukupalli, S., Jing, L., Liu, X., & Zhan, P. (2020). Fsp3: A new parameter for drug-likeness. Drug Discovery Today, 25, 1839\u20131845","journal-title":"Drug Discovery Today"},{"key":"1540_CR53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/092986709787002817","volume":"16","author":"S Prasanna","year":"2009","unstructured":"Prasanna, S., & Doerksen, R. J. (2009). Topological polar surface area: a useful descriptor in 2D-QSAR. Current Medicinal Chemistry, 16, 21\u201341","journal-title":"Current Medicinal Chemistry"},{"key":"1540_CR54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/minf.201400144","volume":"34","author":"OA Raevsky","year":"2015","unstructured":"Raevsky, O. A., Polianczyk, D. E., Grigorev, V. Y., Raevskaja, O. E., & Dearden, J. C. (2015). In silico prediction of aqueous solubility: A comparative study of local and global predictive models. Molecular informatics, 34, 417\u2013430","journal-title":"Molecular informatics"},{"key":"1540_CR55","doi-asserted-by":"crossref","unstructured":"Curtiss, L. A., Redfern, P. C., & Raghavachari, K. (2007). Gaussian-4 theory, The Journal of Chemical Physics, 126","DOI":"10.1063\/1.2436888"},{"key":"1540_CR56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/jcc.21600","volume":"32","author":"AR Allouche","year":"2011","unstructured":"Allouche, A. R. (2011). Gabedit\u2014A graphical user interface for computational chemistry softwares. Journal of Computational Chemistry, 32, 174\u2013182","journal-title":"Journal of Computational Chemistry"},{"key":"1540_CR57","doi-asserted-by":"crossref","first-page":"483869","DOI":"10.1155\/2011\/483869","volume":"2011","author":"C Sharma","year":"2011","unstructured":"Sharma, C., Velpandian, T., Biswas, N. R., Nayak, N., Vajpayee, R. B., & Ghose, S. (2011). Development of novel in silico model to predict corneal permeability for congeneric drugs: a QSPR approach. BioMed Research International, 2011, 483869","journal-title":"BioMed Research International"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01540-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T06:30:46Z","timestamp":1740724246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01540-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1540"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01540-1","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"9 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}